Skip to main content
SpringerLink
Log in

Image-Guided Radio Frequency Ablation of Renal Cancer

  • Reference work entry
  • First Online:
Image-Guided Cancer Therapy

  • 1427 Accesses

Abstract

Incidental small-volume renal tumors are a growing clinical problem, and while partial nephrectomy – open or laparoscopic – remains the standard of care, radiofrequency ablation for sub-4 cm disease has been increasingly confirmed as a viable treatment alternative. This chapter looks at the suitability of renal tumors to percutaneous ablation, radiofrequency ablation equipment, and ablation techniques including imaging, patient sedation, and follow-up regimes. The chapter concludes with a review of the current evidence for RFA and how it compares to surgical treatments of renal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. National Cancer Institute. Surveillance, epidemiology and end results. http://seer.cancer.gov. Accessed June 2010.

  2. American Cancer Society. Facts and figures downloads. http://www.cancer.org. Accessed June 2010.

  3. Chow W, Devesa S, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628–31.

    Article  CAS  PubMed  Google Scholar 

  4. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998;51(2):203–5.

    Article  CAS  PubMed  Google Scholar 

  5. Quinn M, Babb P, et al. Cancer trends in England and Wales 1950–1999, National statistics. http://www.statistics.gov.uk/downloads/theme_health/cancertrends_5099.pdf. Accessed June 2010. or Vol. SMPS No. 66. 2001: TSO.

  6. Adams KF, Leitzmann MF, Albanes D, et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. 2008;168(3):268–77. Epub 9 Jun 2008.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Frank I, Blute M, Cheville J, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170(6 Pt 1):2217–20.

    Article  PubMed  Google Scholar 

  8. Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology. 1995;197(3):589–97.

    Article  CAS  PubMed  Google Scholar 

  9. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175(2):425–31.

    Article  PubMed  Google Scholar 

  10. Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177(3):849–53. discussion 853–4.

    Article  PubMed  Google Scholar 

  11. Cary KC, Sundaram CP. Watchful waiting in the treatment of the small renal mass. Indian J Urol. 2009;25(4):489–93.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Mattar K, Jewett MA. Watchful waiting for small renal masses. Curr Urol Rep. 2008;9(1):22–5.

    Article  PubMed  Google Scholar 

  13. Mues AC, Landman J. Small renal masses: current concepts regarding the natural history and reflections on the American Urological Association guidelines. Curr Opin Urol. 2010;20(2):105–10.

    Article  PubMed  Google Scholar 

  14. Dechet CB, Sebo T, Farrow G, Blute ML, Engen DE, Zincke H. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol. 1999;162(4):1282–4. discussion 1284–5.

    Article  CAS  PubMed  Google Scholar 

  15. Beland MD, Mayo-Smith WW, Dupuy DE, Cronan JJ, DeLellis RA. Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate? AJR. 2007;188:792–7.

    Article  PubMed  Google Scholar 

  16. Rybicki FJ, Shu KM, Cibas ES, Fielding JR, vanSonnenberg E, Silverman SG. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol. 2003;180(5):1281–7.

    Article  PubMed  Google Scholar 

  17. Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency using multiprobe arrays. Acad Radiol. 1995;2(8):670–4.

    CAS  PubMed  Google Scholar 

  18. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol. 2007;189(2):429–36.

    Article  PubMed  Google Scholar 

  19. Skonieczki BD, Wells C, Wasser EJ, Dupuy DE. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe? Eur J Radiol. 2011;79(3):343–6. Epub ahead of print.

    Article  PubMed  Google Scholar 

  20. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969;101(3):297–301.

    CAS  PubMed  Google Scholar 

  21. Van Poppel H, Bamelis B, Oyen R, Baert L. Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control. J Urol. 1998;160(3 Pt 1):674–8.

    Article  PubMed  Google Scholar 

  22. Weight CJ, Lieser G, Larson BT, Gao T, Lane BR, Campbell SC, Gill IS, Novick AC, Fergany AF. Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol. 2010;58(2):293–8 [Epub ahead of print].

    Article  PubMed  Google Scholar 

  23. Marszalek M, Meixl H, Polajnar M, Rauchenwald M, Jeschke K, Madersbacher S. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Eur Urol. 2009;55(5):1171–8. Epub 2009 Feb 20.

    Article  PubMed  Google Scholar 

  24. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Campbell SC, Blute ML. Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol. 2010;58(3):331–6 [Epub].

    Article  PubMed  Google Scholar 

  25. Krambeck AE, Farrell MA, Callstrom MR, Atwell TD, Charboneau JW, Chow GK, Dimarco DS, Patterson DE. Radiofrequency ablation of renal tumors in the solitary kidney. Can J Urol. 2008;15(4):4163–8. discussion 4168.

    PubMed  Google Scholar 

  26. Zlotta AR, Wildschutz T, Raviv G, Peny MO, van Gansbeke D, Noel JC, Schulman CC. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol. 1997;11(4):251–8.

    Article  CAS  PubMed  Google Scholar 

  27. Breen D, Rutherford E, Steadman B, et al. Management of renal tumours by image-guided radiofrequency ablation: experience in 105 tumours. CVIR. 2007;30:936–42.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185(1):64–71.

    Article  PubMed  Google Scholar 

  29. Ginat DT, Saad WE. Bowel displacement and protection techniques during percutaneous renal tumor thermal ablation. Tech Vasc Interv Radiol. 2010;13(2):66–74.

    Article  PubMed  Google Scholar 

  30. DeBenedectis CM, Beland MD, Dupuy DE, et al. Utility of iodinated contrast medium in hydrodissection fluid when performing renal tumor ablation. J Vasc Interv Radiol. 2010;21(5):745–7.

    Article  PubMed  Google Scholar 

  31. Cantwell CP, Wah TM, Gervais DA, Eisner BH, Arellano R, Uppot RN, Samir AE, Irving HC, McGovern F, Mueller PR. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5 % in water. J Vasc Interv Radiol. 2008;19:1034–40.

    Article  PubMed  Google Scholar 

  32. Morales JP, Sabharwal T, Georganas M, Dourado R, Cahill D, Adam A. Cold saline irrigation of the renal pelvis during radiofrequency ablation of a central renal neoplasm: a case report. J Med Case Reports. 2008;2:40.

    Article  PubMed Central  Google Scholar 

  33. Sommer CM, Kortes N, Zelzer S, Arnegger FU, Stampfl U, Bellemann N, Gehrig T, Nickel F, Kenngott HG, Mogler C, Longerich T, Meinzer HP, Richter GM, Kauczor HU, Radeleff BA. Renal artery embolization combined with radiofrequency ablation in a porcine kidney model: effect of small and narrowly calibrated microparticles as embolization material on coagulation diameter, volume, and shape. Cardiovasc Intervent Radiol. 2011;34(1):156–65 [Epub].

    Article  CAS  PubMed  Google Scholar 

  34. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR. 2003;180(6):1503–8.

    Article  PubMed  Google Scholar 

  35. Atwell TD, Carter RE, Schmit GD, Carr CM, Boorjian SA, Curry TB, Thompson RH, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol. 2012;23(1):48–54.

    Article  PubMed  Google Scholar 

  36. Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology. 2011;77(6):1393–7.

    Article  PubMed  Google Scholar 

  37. Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RJ, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006;176(5):1973–7.

    Article  PubMed  Google Scholar 

  38. Gervais DA, McGovern FJ, Wood BJ, et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology. 2000;217:665–72.

    Article  CAS  PubMed  Google Scholar 

  39. Rutherford EE, Cast JE, Breen DJ. Immediate and long-term CT appearances following radiofrequency ablation of renal tumours. Clin Radiol. 2008;63(2):220–30. Epub 2007 Nov 7.

    Article  CAS  PubMed  Google Scholar 

  40. Davenport MS, Caoili EM, Cohan RH, Ellis JH, Higgins EJ, Willatt J, Fox GA. MRI and CT characteristics of successfully ablated renal masses: imaging surveillance after radiofrequency ablation. AJR Am J Roentgenol. 2009;192(6):1571–8.

    Article  PubMed  Google Scholar 

  41. Schirmang TC, Mayo-Smith WW, Dupuy DE, Beland MD, Grand DJ. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation – incidence and clinical importance in 101 consecutive patients. Radiology. 2009;253:263–9.

    Article  PubMed  Google Scholar 

  42. Lokken RP, Gervais DA, Arellano RS, Tuncali K, Morrison PR, Tatli S, Mueller PR, Silverman SG. Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. AJR Am J Roentgenol. 2007;189:845–8.

    Article  PubMed  Google Scholar 

  43. Boss A, Martirosian P, Schraml C, Clasen S, Fenchel M, Anastasiadis A, Claussen CD, Pereira PL, Schick F. Morphological, contrast-enhanced and spin labeling perfusion imaging for monitoring of relapse after RF ablation of renal cell carcinomas. Eur Radiol. 2006;16(6):1226–36.

    Article  PubMed  Google Scholar 

  44. Levinson AW, Su LM, Agarwal D, Sroka M, Jarrett TW, Kavoussi LR, Solomon SB. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol. 2008;180(2):499–504. discussion 504. Epub 2008 Jun 11.

    Article  PubMed  Google Scholar 

  45. Kunkle DA, Egleston RG. Excise, ablate or observe: the small renal mass dilemma – a meta-analysis and review. J Urol. 2008;179:1227–33.

    Article  PubMed  Google Scholar 

  46. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer. 2004;100:738.

    Article  PubMed  Google Scholar 

  47. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow up. J Urol. 2000;163(2):442–5.

    Article  CAS  PubMed  Google Scholar 

  48. Aron M, Gill IS. Partial nephrectomy–why, when, how…? J Urol. 2008;179(3):811–2. Epub 2008 Jan 25.

    Article  PubMed  Google Scholar 

  49. Park S, Anderson JK, Matsumoto ED, et al. Radiofrequency ablation of renal tumours: intermediate-term results. J Endourol. 2006;20:569–73.

    Article  PubMed  Google Scholar 

  50. McDougal WS, Gervais DA, McGovern FJ, Mueller PR. Long-term follow up of patients with renal cell carcinoma treated with radiofrequency ablation with curative inter. J Urol. 2005;174:61–3.

    Article  PubMed  Google Scholar 

  51. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation. Experience from treating 243 small renal masses over 7.5 years. Cancer. 2010;116(13):3135–42.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Imaging, Queen Alexandra Hospital, Southwick Hill Road, Portsmouth, Hampshire, UK

    Peter Osborn

  2. Department of Radiology, Southampton University Hospitals, Tremona Road, Southampton, UK

    David J. Breen

Authors
  1. Peter Osborn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J. Breen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Osborn .

Editor information

Editors and Affiliations

  1. The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging Rhode Island Hospital, Providence, Rhode Island, USA

    Damian E. Dupuy

  2. Department of Surgery and Radiology Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Yuman Fong

  3. McMullen Consulting, LLC, Surprise, Arizona, USA

    William N. McMullen

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this entry

Cite this entry

Osborn, P., Breen, D.J. (2013). Image-Guided Radio Frequency Ablation of Renal Cancer. In: Dupuy, D., Fong, Y., McMullen, W. (eds) Image-Guided Cancer Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0751-6_48

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0751-6_48

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-0750-9

  • Online ISBN: 978-1-4419-0751-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation